IGC

IGC Pharma, Inc.

0.26

USD

IGC Earnings Reports

Positive Surprise Ratio

IGC beat 4 of 6 last estimates.

67%

Next Report

Date of Next Report

Feb 18, 2026

Estimate for Q3 26 (Revenue/ EPS)

$328.25K

-$0.01

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

+27.72%

-50.00%

IGC Pharma, Inc. earnings per share and revenue

On Nov 17, 2025, IGC reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 328.25 thousand, with a --% difference. The market reacted with a -5.03% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 2 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 328.25 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were IGC Pharma, Inc.'s earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, IGC Pharma, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to IGC Pharma, Inc.'s Q2 2026 earnings?

The stock price moved down -5.03%, changed from $0.36 before the earnings release to $0.34 the day after.

When is IGC Pharma, Inc. expected to report next?

The next earning report is scheduled for Feb 18, 2026.

What are the forecasts for IGC Pharma, Inc.'s next earnings report?

Based on 2 analysts, IGC Pharma, Inc. is expected to report EPS of -$0.01 and revenue of $328.25K for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.